Possible Repositioning of an Oral Anti-Osteoporotic Drug, Ipriflavone, for Treatment of Inflammatory Arthritis via Inhibitory Activity of KIAA1199, a Novel Potent Hyaluronidase

KIAA1199 has a strong hyaluronidase activity in inflammatory arthritis. This study aimed to identify a drug that could reduce KIAA1199 activity and clarify its effects on inflammatory arthritis. Rat chondrosarcoma (RCS) cells were strongly stained with Alcian blue (AB). Its stainability was reduced...

Descripción completa

Detalles Bibliográficos
Autores principales: Koike, Hiroshi, Nishida, Yoshihiro, Shinomura, Tamayuki, Ohkawara, Bisei, Ohno, Kinji, Zhuo, Lisheng, Kimata, Koji, Ushida, Takahiro, Imagama, Shiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030858/
https://www.ncbi.nlm.nih.gov/pubmed/35456905
http://dx.doi.org/10.3390/ijms23084089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030858/
https://www.ncbi.nlm.nih.gov/pubmed/35456905
http://dx.doi.org/10.3390/ijms23084089

Ejemplares similares